SCHEMBL6488975

SCHEMBL6488975

Cc1cc(CNc2cc(C(=O)OC(C)C)ccn2)cc2c1nc(C)n2Cc1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.34
ITGB3 P05106 2/20 0.34
ITGB1 P05556 2/20 0.34
ITGAV P06756 2/20 0.34
ITGA2B P08514 2/20 0.34
ITGA5 P08648 2/20 0.34
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
LTC4S Q16873 1/20 0.34
AGTR1 P30556 4/20 0.33
PPARG P37231 4/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
DCTPP1 Q9H773 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
BDKRB1 P46663 1/20 0.33
PYGL P06737 1/20 0.32
PYGM P11217 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6500955 0.90 KDM4C (0.40) ALOX5APITGB3ITGB1ITGAVITGA2B
SCHEMBL6487346 0.87 ALDH1A1 (0.38) ALOX5APPTGESALOX5LTC4SAGTR1
SCHEMBL6489174 0.80 PIK3C2B (0.37) ALOX5APPTGESALOX5LTC4SAGTR1
SCHEMBL6490213 0.77 MRGPRX4 (0.40) ALOX5APPTGESALOX5LTC4SPPARG
SCHEMBL6489503 0.76 CYSLTR1 (0.42) PPARGDCTPP1
SCHEMBL6492577 0.75 DCTPP1 (0.41) ALOX5APPTGESALOX5LTC4SDCTPP1
SCHEMBL6488028 0.74 AGTR1 (0.40) AGTR1DCTPP1
SCHEMBL6486764 0.74 DCTPP1 (0.44) ALOX5APPTGESALOX5LTC4SAGTR1
SCHEMBL6503273 0.74 CYP1A2 (0.42) AGTR1PPARGMEN1KMT2A
SCHEMBL6501198 0.73 NR4A2 (0.48) ALOX5APPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD ALOX5AP 4663/4885ITGB3 2674/4885ITGB1 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.